Interstitial lung disease in rheumatoid arthritis: incidence, prevalence and related drug prescriptions between 2007 and 2020
Objective To investigate prevalence, incidence and medication of interstitial lung disease (ILD) among German individuals with rheumatoid arthritis (RA).Methods Nationwide BARMER claims data from 2007 to 2020 were used. RA-ILD was identified by diagnosis codes, prescription of disease-modifying anti...
Main Authors: | Johanna Callhoff, Katinka Albrecht, Anja Strangfeld, Ursula Marschall |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-01-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/9/1/e002777.full |
Similar Items
-
High burden of polypharmacy and comorbidity in persons with psoriatic arthritis: an analysis of claims data, stratified by age and sex
by: Johanna Callhoff, et al.
Published: (2023-03-01) -
Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data
by: Florian Milatz, et al.
Published: (2024-01-01) -
Interstitial lung disease in rheumatoid arthritis
by: Laura Groseanu
Published: (2023-12-01) -
Interstitial lung involvement in rheumatoid arthritis
by: David Vladimirovich Bestaev, et al.
Published: (2014-12-01) -
INTERSTITIAL LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS
by: David Vladimirovich Bestaev, et al.
Published: (2012-12-01)